missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18662018

TOP2A Antibody (TOP2A/1361), FITC, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-54546F

Product Code. 18662018

  • € 605.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TOP2A Monoclonal antibody specifically detects TOP2A in Human, Mouse samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin), Protein Array, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TOP2A
Monoclonal
FITC
DNA topoisomerase (ATP-hydrolyzing), DNA topoisomerase 2-alpha, DNA topoisomerase II, 170 kD, DNA topoisomerase II, alpha isozyme, EC 5.99.1.3, TOP2DNA gyrase, topoisomerase (DNA) II alpha (170kD), topoisomerase (DNA) II alpha 170kDa, TP2A
Recombinant human TOP2A fragment (aa1352-1493) (Uniprot: P11388)
100 μg
Cancer, Cell Cycle and Replication, Core ESC Like Genes, DNA Repair, Stem Cell Markers
7153
Store at 4°C in the dark.
IgG2b κ
Western Blot, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Protein Array
TOP2A/1361
PBS
Mouse
Protein A or G purified
RUO
Primary
Human, Mouse
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.